Live tape
Top 8, mentions 7d9,843TSLA2,036 mentions▲ +0.05GOOGL1,581 mentions▲ +0.04NVDA1,205 mentions▲ +0.07CRWV1,192 mentions▲ +0.03SPCX1,069 mentions▲ +0.07QQQ1,042 mentions▲ +0.04META873 mentions▲ +0.05NBIS845 mentions▲ +0.05

Equity · Healthcare

PHVS

NASDAQ

Pharvaris N.V.

$35 +3.83% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close)
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for PHVS to draw a line in its place.

52-week range $19.57 – $36
Avg volume 121.1K

as of Jul 17, 2026

Filings 2 sets

PHVS institutional holders

SEC Form 13F SEC EDGAR

8 of the 45 institutional funds we track reported a PHVS position for the quarter ended 30 Jun 2026 — a combined $248.6M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Viking Global Investors Held (±25%) 3,653,310 $126.3M
Point72 Asset Management Added +63.0% shares 1,641,200 $56.8M
Balyasny Asset Management Held (±25%) +13.4% shares 524,302 $18.1M
D. E. Shaw & Co. Added +46.8% shares 471,402 $16.3M
Millennium Management Added +134.9% shares 427,403 $14.8M
Citadel Advisors Added +43.4% shares 241,785 $8.4M
Two Sigma Investments Added +71.8% shares 216,640 $7.5M
Tudor Investment Corp Trimmed −57.5% shares 13,147 $455K

PHVS fails-to-deliver

SEC CNS data SEC

On 14 Sep 2026, 50 shares of PHVS failed to deliver (about $2K).

Settlement date Shares failed Notional % of shares out
14 Sep 2026 50 $2K <0.001%

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR 13F filings
  4. SECSEC fails-to-deliver (CNS) data